Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeuticscmn (NQ: TGTX )

14.60 -0.19 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,293,957
Open 14.92
Bid (Size) 14.50 (1)
Ask (Size) 14.60 (2)
Prev. Close 14.79
Today's Range 14.37 - 14.93
52wk Range 3.480 - 19.59
Shares Outstanding 146,363,127
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. 
Via Benzinga
Where TG Therapeutics Stands With Analysts
 
Via Benzinga

Performance

YTD
+26.19%
+26.19%
1 Month
-10.26%
-10.26%
3 Month
+81.59%
+81.59%
6 Month
+116.94%
+116.94%
1 Year
+50.52%
+50.52%

More News

Read More
Top 5 Health Care Stocks That May Collapse In February
Via Benzinga
Here's How Much $100 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
Via Benzinga
The Latest Analyst Ratings for TG Therapeutics
Via Benzinga
Here's How Much $1000 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
Via Benzinga
'A Class Action Lawsuit Against TG Therapeutics Has Been Dismissed'
Via Benzinga
Earnings Scheduled For February 28, 2023
Via Benzinga
Why TG Therapeutics Stock Was a Solid Winner This Week
Via The Motley Fool
Analyst Ratings for TG Therapeutics
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
Via Benzinga
B of A Securities Maintains Underperform Rating for TG Therapeutics: Here's What You Need To Know
Via Benzinga
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
Via Benzinga
TG Therapeutics Stock 300% Rally Has Legs Yet
Via MarketBeat
Exposures COVID-19 Product Safety
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Via Benzinga
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Via Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
Via Benzinga
Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
Via Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
What's Going On With TG Therapeutics Shares
Via Benzinga
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday
Via Benzinga
Tesla, Hyzon Motors And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.